Patent application number | Description | Published |
20110136846 | Buprenorphine Analogs - The present invention is directed to Buprenorphine Analog compounds of the Formula I, Formula II or Formula III shown below, wherein R | 06-09-2011 |
20130296247 | Analogs of Sodium Channel Peptide Toxin - The present invention relates to a peptide and analogs thereof that selectively inhibit the Na | 11-07-2013 |
20130296281 | Aryl Substituted Indoles and Their Use as Blockers of Sodium Channels - The invention relates to aryl and heteroaryl substituted compounds of Formula (I), and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein G, R | 11-07-2013 |
20130345211 | Pyridine Compounds as Sodium Channel Blockers - The invention relates to substituted pyridine compounds of Formula I: (I) or a pharmaceutically acceptable salt, prodrug, or solvate thereof wherein A | 12-26-2013 |
20140050749 | MHC-I Restricted Epitopes Containing Non-Natural Amino Acid Residues - The invention provides for the synthesis of more effective generators of a T-cell immune response by providing peptide derivatives that are MHC class I-restricted antigens. The peptide derivatives of the present invention are prepared or derived from a parent peptide of 8 to 11 amino acid residues in length, wherein the peptide derivative contains a non-natural amino acid substituted in place of a naturally-occurring amino acid residue at one or more primary anchor positions in the parent peptide or at position 6, position 7, or the C-terminus. The exemplary polypeptides are derived from the survivin, hTERT, CYP1B1 and MART-1 antigens. | 02-20-2014 |
20140057931 | BUPRENORPHINE ANALOGS - The present invention is directed to Buprenorphine Analog compounds of the Formula (I), Formula (IA) or Formula (IB) shown below, wherein R | 02-27-2014 |
20140187571 | 7,8-Cyclicmorphinan Analogs - The application is directed to compounds of Formula I-A | 07-03-2014 |
20140364448 | QUARTERNIZED BUPRENORPHINE ANALOGS - The present invention is directed to Buprenorphine Analog compounds of the Formula (I), Formula (IA) or Formula (IB) shown below, wherein R | 12-11-2014 |